Amino Acids Antioxidants Bioflavonoids Celloids & Tissue Salts Coenzyme Q10 Colloidal Enzyme Fish Oils Flower Essences Food Glucosamine Glutamine Health Herbs Homoeopathics Minerals Mother & Baby Care Mushroom Formulas Other ph Balancing Plant Oils Probiotics Protein Topical Applications Vitamins Wholefoods & Superfoods Miscellaneous Baby Batteries Beverages Chocolates Cleaning / Sponge / Glove / Wipe Cleaning Products Clothing / Footwear Confectionary Crackers & Snacks Dishwashing Liquid Feminine Hygiene First Aid & Medicinal Gift Sets Grocery Gym Equipment Household Consumables Insect Control Laundry Care LIGHTERS Miscellaneous Paper Towels Party, Picnic & BBQ Needs PET ACCESSORIES Tissues Toilet Cages Toilet Tissues Toys Wipes & Powders The Cosmetics Collective Amino Acids Chocolate & Confectionary Flours, Cereals, Grains & Seeds Health Juices & Drinks Honey Muesli & Dried Fruits Other Protein & Health Bars Protein Powders & Drinks Sauces & Seasonings Spreads & Butters Sweeteners Tea & Coffee Vegetable Oils Vinegars Health Cardiovascular Childrens Cold & Flu Digestion & Detoxification Ear, Nose & Throat Endocrine System Energy & Sleep Eyes Hair, Skin & Nails Healthy Ageing Immunity & Allergies Joints Liver Musculoskeletal Nervous System Pain & Inflammation Respiratory Urinary Minerals Mother & Baby Care Vitamins Folate Multi Vitamins Vitamin A Vitamin B Complex Vitamin B12 Vitamin B3 Vitamin B6 Vitamin C Vitamin D Vitamin E Vitamin K Miscellaneous Baby Batteries Confectionary Insect Control Toys
J Clin Invest 2010;120:1774-85
Influence of coating materials on ASD stability Many active pharmaceutical ingredients (APIs) suffer from low aqueous solubility, limiting their bioavailability
Some research indicates this can lead to increased endurance, reduced fatigue, and enhanced recovery during and following exercise
It is typically supplied as a lyophilized powder in a vial with no guarantee of sterility, endotoxin control, or the identity-and-purity verification that a compounded or approved injectable would carry
Phase 3 planned for obesity (2025) and T2D (2026)
